Cargando…
Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
Soft tissue sarcomas (STS) are heterogeneous rare malignancies comprising ~1% of all solid cancers in adults and including more than 70 histological and molecular subtypes with different pathological and clinical development characteristics. Over the last two decades, the increased knowledge of the...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174622/ https://www.ncbi.nlm.nih.gov/pubmed/32351891 http://dx.doi.org/10.3389/fonc.2020.00509 |